8. Hoffmann-La Roche Ltd PDF Print E-mail

Project leader:

Dr. Frédéric Knoflach


Involved staff:

PD Dr. Gerhard Trube



Ben van Lier 



Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.

Pharma Research and Early Development (pRED) drives and delivers world-class science through its discovery groups operating with great diversity of therapeutic modalities and profound translational and diagnostics capabilities

The Neuroscience Disease and Translational Area  (DTA) oversees the discovery, research and development of novel treatments for diseases such as schizophrenia, multiple sclerosis, and Alzheimer’s disease.

Within the Cellular Neuroscience division of the Neuroscience DTA, the electrophysiology department supports drug discovery with extracellular measurements, patch clamping and microelectrode arrays. In close collaboration with EngCaBra partner ETHZ we will focus on schizophrenia mouse models for use on the microelectrode arrays.